Debora Dowda
Nurse Practitioner · Bartlett, TNNPI 1124059365
Payments from drug & device makers
Across 198 payments — averaging $17.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$601
- Lilly USA, LLC$519
- AbbVie$488
- AstraZeneca$377
- Abbott$219
- Boehringer Ingelheim$163
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,433100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $601 |
| Lilly USA, LLC | 33 | $519 |
| AbbVie | 36 | $488 |
| AstraZeneca | 17 | $377 |
| Abbott | 11 | $219 |
| Boehringer Ingelheim | 11 | $163 |
| Amarin Pharma, Inc. | 10 | $150 |
| Amgen | 7 | $143 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| GSK | 6 | $90 |
| Bardy Diagnostics, Inc. | 1 | $75 |
| Pfizer | 5 | $74 |
| Biohaven Pharmaceuticals, Inc. | 4 | $56 |
| Exact Sciences | 3 | $50 |
| Abiomed | 1 | $41 |
| Johnson & Johnson | 3 | $41 |
| Mylan Specialty L.p. | 2 | $34 |
| Inogen, Inc. | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Clarus Therapeutics Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Recor Medical Inc | 1 | $18 |
| Ascensia Diabetes Care US Inc. | 1 | $16 |
| Shield Therapeutics Inc | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Antares Pharma, Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$3,433 in reported general payments places this provider in the 85th percentile of 2,662 nurse practitioner providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 73 | $82,191 |
| EliquisApixaban | 64 | $62,397 |
| JardianceEmpagliflozin | 41 | $54,844 |
| JanuviaSitagliptin Phosphate | 47 | $40,166 |
| MounjaroTirzepatide | 36 | $32,814 |
| RybelsusSemaglutide | 20 | $31,902 |
| FarxigaDapagliflozin Propanediol | 26 | $23,390 |
| TrulicityDulaglutide | 15 | $22,336 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $16,112 |
| XareltoRivaroxaban | 23 | $15,840 |
| Spiriva HandihalerTiotropium Bromide | 13 | $6,457 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $4,936 |
| Metoprolol Succinate | 233 | $3,095 |
| Levothyroxine Sodium | 321 | $2,999 |
| Pantoprazole Sodium | 157 | $2,829 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $601 | $114,09293 claims |
| PfizerEliquis | $74 | $62,39764 claims |
| Lilly USA, LLCMounjaro, Trulicity | $519 | $55,15051 claims |
| Boehringer IngelheimJardiance | $163 | $54,84441 claims |
| AstraZenecaFarxiga, Symbicort | $377 | $28,32539 claims |
| Johnson & JohnsonXarelto | $41 | $15,84023 claims |
| AbbVieSynthroid | $488 | $1,83051 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,662 nurse practitioner providers in Tennessee.
Other nurse practitioner in Bartlett
- Allison KingBartlett$14K
- Amy HatcherMurfreesboro$1.1M
- Karen RodenKnoxville$265K
- Susan UtleyNashville$194K
- Whitney EricksonMemphis$159K
- Erica HembreeKnoxville$125K
- Brooke FaughtNashville$89K
- Lauren WelchNashville$71K
- Cara StoutKingsport$71K
- S Marie HamiltonOoltewah$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.